L-arginine fails to prevent ventricular remodeling and heart failure in the spontaneously hypertensive rat. (Q46213457)

20 December 2017

title

L-arginine fails to prevent ventricular remodeling and heart failure in the spontaneously hypertensive rat. (English)

1 reference

20 December 2017

main subject

heart failure

0 references

ventricular remodeling

1 reference

Wesley W Brooks

1

1 reference

20 December 2017

Chester H Conrad

2

1 reference

20 December 2017

Kathleen G Robinson

3

1 reference

20 December 2017

Wilson S Colucci

4

1 reference

20 December 2017

Oscar H L Bing

5

1 reference

20 December 2017

publication date

4 December 2008

1 reference

20 December 2017

Journal of Clinical Hypertension

published in

1 reference

20 December 2017

volume

22

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

page(s)

228-234

1 reference

20 December 2017

https://api.crossref.org/works/10.1038%2FAJH.2008.334

1 reference

7 January 2021

Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hypertensive rat

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

L-arginine in the management of cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

Oral L-arginine does not improve endothelial dysfunction in children with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

Randomized, double-blind, placebo-controlled study of arginine supplementation in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

L-arginine supplementation in peripheral arterial disease: no benefit and possible harm

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

Dietary arginine fails to protect against cerebrovascular damage in stroke-prone hypertensive rats.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

L-arginine and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

Chronic L-arginine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

Prolonged L-arginine on cardiovascular mass and myocardial hemodynamics and collagen in aged spontaneously hypertensive rats and normal rats

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

Adverse effects of supplemental L-arginine in atherosclerosis: consequences of methylation stress in a complex catabolism?

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

Does nitric oxide modulate mitochondrial energy generation and apoptosis?

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

Nitric oxide in heart failure: friend or foe

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

Nitric oxide synthase inhibition in spontaneously hypertensive rats. Systemic, renal, and glomerular hemodynamics

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

L-arginine reverses severe nephrosclerosis in aged spontaneously hypertensive rats.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

Effects of L-arginine on endothelial and cardiac function in rats with heart failure

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

Chronic L-arginine treatment increases cardiac cyclic guanosine 5'-monophosphate in rats with aortic stenosis: effects on left ventricular mass and beta-adrenergic contractile reserve

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

Ramipril improves nitric oxide availability in hypertensive rats with failing hearts after myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

Taurine improves angiotensin II-induced hypertrophy of cultured neonatal rat heart cells.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

Interaction between the actions of taurine and angiotensin II.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

Modulation of left and right ventricular beta-adrenergic receptors from spontaneously hypertensive rats with left ventricular hypertrophy and failure

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

Long-term administration of L-arginine did not influence blood pressure, heart rate, cardiac hypertrophy or arterial wall thickness of spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

L-arginine fails to protect against myocardial remodelling in L-NAME-induced hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

L-arginine supplementation accelerates renal fibrosis and shortens life span in experimental lupus nephritis

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

Arginine nutrition and cardiovascular function

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

Chronic oral administration of arginine induces GH gene expression and insulin resistance.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

Regression of cardiac hypertrophy. Experimental animal model

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

Inhibition of NF-kappaB induces regression of cardiac hypertrophy, independent of blood pressure control, in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2008.334

7 January 2021

Identifiers

DOI

10.1038/AJH.2008.334

1 reference

20 December 2017

PubMed ID

19057517

1 reference

20 December 2017